Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Convertible Debt (2018 - 2022)

Historic Convertible Debt for Verastem (VSTM) over the last 5 years, with Q3 2022 value amounting to $268000.0.

  • Verastem's Convertible Debt rose 1028.81% to $268000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $268000.0, marking a year-over-year increase of 1028.81%. This contributed to the annual value of $249000.0 for FY2021, which is 9869.3% down from last year.
  • Per Verastem's latest filing, its Convertible Debt stood at $268000.0 for Q3 2022, which was up 1028.81% from $262000.0 recorded in Q2 2022.
  • Over the past 5 years, Verastem's Convertible Debt peaked at $101.2 million during Q3 2019, and registered a low of $243000.0 during Q3 2021.
  • For the 5-year period, Verastem's Convertible Debt averaged around $36.4 million, with its median value being $20.1 million (2020).
  • As far as peak fluctuations go, Verastem's Convertible Debt tumbled by 9883.4% in 2021, and later surged by 1028.81% in 2022.
  • Quarter analysis of 5 years shows Verastem's Convertible Debt stood at $95.2 million in 2018, then fell by 28.01% to $68.6 million in 2019, then plummeted by 72.21% to $19.1 million in 2020, then plummeted by 98.69% to $249000.0 in 2021, then rose by 7.63% to $268000.0 in 2022.
  • Its Convertible Debt was $268000.0 in Q3 2022, compared to $262000.0 in Q2 2022 and $255000.0 in Q1 2022.